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Abstract 
A cross-sectional study was conducted to determine the seroprevalence of major transfusion-transmissible infections 
among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. The overall seroprevalence of major blood-
borne pathogens among blood donors was 43.2%, of which HBsAg, anti-HCV IgG, HIV seropositivity and syphilis 
accounted for 25%, 13.3%, 11.7% and 1.2% respectively. Crude seroprevalence of major blood born pathogens was 
significantly higher in commercial blood donors (56.6%) compared to voluntary (17.6%) and replacement blood 
donors (53.6%) (p=0.0001).  [Ethiop.J.Health Dev. 2007;21(1):68-69] 
 
Introduction 
Although blood transfusion is one of the known 
therapeutic interventions that cut across a number of 
clinical disciplines, the practice is not without risks. In 
Africa, about 10-15 % of HIV transmission had been 
related to blood transfusions (1) .The highest risk groups 
are children suffering from malaria and anaemia; women 
with pregnancy- related haemorrhage and victims of 
major trauma.  
 
Felege Hiowt Referral Hospital is a 245 bed hospital 
located in Bahir Dar city, northwest Ethiopia. Being 
situated in a malaria dominant area, blood transfusion is 
one of the routine services in this hospital. However, 
most of the donated blood is screened for HIV alone. The 
national HIV prevalence among blood donors is 4.7 %( 
6). However, there is paucity of information about the 
true burden of major transfusion-transmissible infections 
in the study area. The purpose of this study is, therefore, 
to determine the seroprevalence of common blood-borne 
infections among the donor population. 
 
Methods 
A cross-sectional study was conducted at Felege Hiwot 
Referral Hospital and Bahir Dar Regional Health 
Research Laboratory from February 2006 to May 2006. 
Exclusion criteria for blood donation were current history 
of medication, recent history of operation, serious illness, 
previous blood transfusion, weight < 50kg, pregnant and 
lactating women, age <18  and > 60 years and blood 
donation for 3 months prior to the current study. 
Applying these criteria, 324 apparently healthy blood 
donors who donated blood were included in the study. At 
the time of blood collection, socio-demographic variables 
of the study population were collected using a structured 
questionnaire. In this study, commercial donor is a donor 
who gives blood for money or other form of payment and 
a replacement donor is a donor who gives blood when it 
is required by a member of the patient's family. 
 
Serological assays for HIV infection, Hepatitis B virus, 
Hepatitis C virus and Syphilis were screened by using 4th 
generation ELISA, Vironostika HIV Uni-Form II AG/Ab 
(Bio-Merieux, Boxtel, Netherlands), an immunoassay  
 
ELISA Hepanostika HBSAg UNi-Form II (Bio-Merieux, 
Boxtel, Netherlands), using the Human anti-HCV 3rd 
generation ELISA (Human Gasellschaft for Bio-chemical 
and diagnostic MbH, Germany) and using Rapid Plasma 
Reagnic (BHAT-BIO-TECH, Banglor, India) 
respectively.  Pearson Chi-Square and 95% confidence 
interval were employed for group comparison of blood 
donors and association of variables. 
  
Results 
A total of 324 blood donors including 283 males and 41 
females donated blood during the study period, out of 
which 152 (46.9%), 138 (42.6% ) and 34 (10.5% ) were 
commercial, replacement and voluntary donors 
respectively. The overall seroprevalence of major blood-
borne pathogens (HIV, HBV, HCV and syphilis) among 
blood donors was 43.2 %. Seroprevalence of hepatitis B 
virus was the highest (25%) followed by hepatitis C virus 
(13.3%), human immunodeficiency virus (11.7%) and 
syphilis (1.2%) (Table: 1). The crude seroprevalence of 
major blood born pathogens was significantly higher in 
commercial (56.6%) blood donors compared to voluntary 
(17.6%) and replacement blood donors (53.6%) at 
p=0.001). 
 
Among multiple infected blood donors, HIV seropositive 
blood donors (31.6%) were found to be significantly co-
infected with HBV, HCV and syphilis compared with 
HIV seronegative blood donors (4.9%) at P=0.0001. 
Among the co-infections HBV and HCV infections were 
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Table 1: Seroprevalence of transfusion-transmissible 
infections among blood donors at Felege Hiwot 






HBV 81 25 
HCV 43 13.3 
HIV 38 11.7 
Syphilis 4 1.2 
None of the screened  TTIs 184 56.8 
Total 324 100.00 
 
Discussion 
This study demonstrated that the seroprevalence of 
blood-borne infections in the donor population is 
unacceptably high (43.2%).This finding is by and large 
higher than similar reports from other developing 
settings. Occurrence of at least one pathogen among 
blood donors was reported to be 15.9% and 26.2% from 
studies in Tanzania and Cameroon respectively (2, 3). 
Hence, even when compared with other resource-
constrained settings, the burden of transfusion-
transmissible infections is quite high in our study 
population. 
 
As with a case of previous report from South Africa (4), 
the prevalence of HIV infection in the blood donor 
population was found to be high (11.7%). Nearly a 
decade ago, Rahlenbeck SI et al (7) reported a 16.7% 
prevalence of HIV infection among Ethiopian blood 
donors. Another local research work from Gondar 
showed crude seroprevalence of HIV was 10.6% in men 
and 11.9% in women among a similar study population 
which is in parallel with our finding (8).  
 
Consistent with the findings of this study, the prevalence 
of HBV infection was reported to be higher than that of 
HCV infection in another East African study (5). We 
found that 8% of the overall blood donors and 18.6% of 
the infected persons had co-infections. One of the other 
important findings we observed in this study was the 
statistically significant occurrence of dual blood-born 
infections among seropositive donors with HIV infection 
than the scenario in HIV seronegative ones. Such a 
higher prevalence of co-infections among HIV infected 
persons is likely to have a clear implication in the routine 
clinical care of HIV infected patients. 
 
In agreement with the findings of this study, other 
research work also demonstrated high infection burden 
among commercial blood donors while voluntary donors 
were found to be comparatively safe (2).In this research 
work,  more  than  half (56.6%) of  the blood donors were 
commercial, which is one of the clear explanations for 
the unacceptably high prevalence of transfusion-
transmissible infections. In conclusion, blood safety is an 
issue of major concern at Felege Hiwot Referral Hospital.  
Hence, blood donations should be routinely screened for 
HIV, HBV, HCV and syphilis using standard methods. A 
strict selection criterion of donors, with emphasis on 
getting voluntary donors is also highly recommended.  
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